SATURDAY, June 7, 2025 (HealthDay News) — You’re not just getting older, you’re probably getting bigger. Between their 20s and 40s, most Americans can expect to put on 10 to 25 pounds — and after 30, exercise may not have the same payoff it once did. It’s not just you,Continue Reading
THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment. But experts say access is still limited, and more research on its long-term safety in teens is needed, NBC News reported. Prescriptions of WegovyContinue Reading
THURSDAY, June 5, 2025 (HealthDay News) — People who get weight-loss surgery experience an improvement in their mental health, but not because of the weight they lose, a new study says. Rather, these patients face much less societal stigma over their weight, and it’s that – not the actual weightContinue Reading
TUESDAY, June 3, 2025 (HealthDay News) — Being your own boss might seem potentially stressful, but self-employed women appear to have better heart health than those toiling for a company, a new study says. Women working for themselves had lower rates of obesity, physical inactivity, poor diet and sleeplessness, researchersContinue Reading
THURSDAY, May 29, 2025 (HealthDay News) — Belly flab appears to be a stronger warning sign for psoriasis than fat located elsewhere on the body, a new study says. Fat around the abdomen is more strongly linked to psoriasis risk that total body fat, particularly in women. “Our research showsContinue Reading
WEDNESDAY, May 28, 2025 (HealthDay News) — Losing just 6.5% of body weight in midlife may lower later risk of disease and premature death, new research shows. Researchers found that people who lost about 6.5% of their body weight — without using weight loss drugs or surgery — reaped bigContinue Reading
WEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic and Zepbound can help reduce a woman’s risk for as many as 14 cancers associated with obesity, a new study says. People taking a GLP-1 drug had a 7% lower risk of developing an obesity-related cancerContinue Reading
FRIDAY, May 23, 2025 (HealthDay News) — A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported.Continue Reading
MONDAY, May 19, 2025 (HealthDay News) — Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk even beyond the benefits from dropping excess pounds, a new study says. First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of obesity-related cancers, compared withContinue Reading
FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases. The deal could be worth up to $2.2 billion for Septerna. This includes more than $200 million inContinue Reading